Catalytic Wealth RIA LLC bought a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 9,276 shares of the company’s stock, valued at approximately $1,438,000. Several other institutional investors and hedge funds also recently made […]
Provident Investment Management Inc. boosted its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 11.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,695 shares of the company’s stock after acquiring an additional 388 shares […]
Weiss Asset Management LP bought a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 5,110 shares of the company’s stock, valued at approximately $792,000. A number of other large investors […]
Pine Valley Investments Ltd Liability Co increased its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 10.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 49,330 shares of the company’s stock after buying an additional 4,850 shares during the quarter. Pine Valley Investments Ltd Liability Co’s holdings in AbbVie were […]
Staley Capital Advisers Inc. trimmed its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 24.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,895 shares of the company’s stock after selling 600 shares during the period. Staley Capital Advisers Inc.’s holdings […]